Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BioLife Solutions, Inc. (BLFS) vs Kestra Medical Technologies, Ltd. (KMTS)

BioLife Solutions, Inc. and Kestra Medical Technologies, Ltd. are both Medical Instruments & Supplies companies. BioLife Solutions, Inc. is the larger, with a market value of $1.9B against $1.5B — 1.2× the size. Kestra Medical Technologies, Ltd. has negative trailing earnings, so its P/E is not meaningful; BioLife Solutions, Inc. trades at 32.6×. Kestra Medical Technologies, Ltd. grew revenue faster over the last twelve months: 60.7% against 30.1%. BioLife Solutions, Inc. has the higher net margin (54.4% vs −140.4%) and the higher return on invested capital (0.32% vs −93.5%). Across the 17 metrics below, BioLife Solutions, Inc. leads on 13 and Kestra Medical Technologies, Ltd. on 4.

Valuation

Metric BLFS KMTS Medical Instruments & Supplies median
P/E 32.62 n/m 34.17
P/S 17.63 14.89 2.83
P/B 4.48 7.15 2.82
Price to free cash flow 232.01 n/m 25.69
EV/EBITDA 350.25 n/m 16.08
EV/Sales 16.99 13.71 3.06
Earnings yield 3.07% (9.85%) (1.84%)
Free cash flow yield 0.43% (7.74%) 0.17%

Profitability

Metric BLFS KMTS Medical Instruments & Supplies median
Gross margin 63.61% 53.89% 54.62%
Operating margin 1.64% (134.48%) 1.64%
Net margin 54.35% (140.43%) 0.00%
Free cash flow margin 7.60% (115.31%) 1.61%
Return on equity 15.12% (73.74%) 0.00%
Return on assets 13.89% (48.85%) 0.00%
Return on invested capital 0.32% (93.49%) 0.00%

Growth

Metric BLFS KMTS Medical Instruments & Supplies median
Revenue growth (TTM) 30.12% 60.72% 9.20%
EPS growth (last fiscal year) 77.27% 52.63% —
Revenue growth, 5-year CAGR 14.88% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BLFS KMTS Medical Instruments & Supplies median
Debt to equity 0.00 0.33 0.08
Current ratio 9.69 4.69 2.49
Net debt to EBITDA 7.04 1.24 0.83

Dividend

Metric BLFS KMTS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric BLFS KMTS Medical Instruments & Supplies median
Market cap 1.91b 1.53b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack